Science News (Scientific Sessions)


Science News from Scientific Sessions 2014

This is your home for comprehensive Science News coverage of the most interesting, important and ground-breaking studies and scientific developments.

Watch all of our Science News videos on the AHAScienceNews YouTube Channel's Scientific Sessions 2014 Playlist:
 


NOTE: Links to materials below will be live after embargo times lift. Please check back throughout the day to see updated material.

Saturday
Resucitation Science
Statewide Implementation of a Standardized Prearrival Telephone CPR Program Is Associated with Increased Bystander CPR and Survival from Out-of-Hospital Cardiac Arrest
Session III: - Best of the Best Oral Abstract Presentations and Presentation of the Best Abstract Awards for Cardiac and Trauma Resuscitation Science

Early PCI Is Associated with Short- and Long-Term Outcome After Out-of-Hospital Cardiac Arrest
Session V: - Best Original Resuscitation Science - Oral Abstract Presentations

Sunday
Late Breaking Clinical Trials
Video: Overview of LBCT.01
Elliott Antman, President of the American Heart Association

Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent
LBCT.01 - Risk and Benefit of Dual Antiplatelet Therapy

Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
LBCT.01 - Risk and Benefit of Dual Antiplatelet Therapy

Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
LBCT.01 - Risk and Benefit of Dual Antiplatelet Therapy

Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study
LBCT.01 - Risk and Benefit of Dual Antiplatelet Therapy


Resucitation Science
Increasing Compression Rate and Depth Positively Correlate with End-Tidal Carbon Dioxide During Actual CPR Performance
Session X: - Best Original Resuscitation Science - Oral Abstract Presentations

Remote Limb Ischemic Postconditioning Improves Postresuscitation Cerebrovascular Circulation and Survival/Neurological Prognoses via In Situ and Remote Activation of Akt-eNOS-NO Signaling Pathway
Session XIV: - Best Original Resuscitation Science - Oral Abstract Presentations

Monday
Late Breaking Clinical Trials
Video: Overview of LBCT.02
Elliot Antman, MD; Clyde Yancy, MD; Neil Stone, MD

IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
LBCT.02 - Anti-Lipid Therapy and Prevention of CAD

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial
LBCT.02 - Anti-Lipid Therapy and Prevention of CAD

Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial
LBCT.02 - Anti-Lipid Therapy and Prevention of CAD

ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm
LBCT.02 - Anti-Lipid Therapy and Prevention of CAD


Clinical Science: Special Reports - Morning
Impact of a Multidisciplinary Management Program on Recurrent Hospitalization and Mortality in Older Individuals With Chronic Atrial Fibrillation: A Multicentre Randomized Trial
CS.03 - Management of Cardiovascular Disease

Efficacy and Safety of ZS-9 in Patients with Hyperkalemia: Results from the HyperkAlemia RandoMized interventiON multI-dose ZS-9 maintEnance (HARMONIZE) Clinical Trial
CS.03 - Management of Cardiovascular Disease

Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT) Trial
CS.03 - Management of Cardiovascular Disease

Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor PCC
CS.03 - Management of Cardiovascular Disease

ANNEXA™-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, Demonstrating Reversal of Apixaban-Induced Anticoagulation in Older Subjects by Andexanet alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors
CS.03 - Management of Cardiovascular Disease


Clinical Science: Special Reports - Afternoon
The Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor (ARNI) With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial
CS.02 - Off the Beaten Pathologies

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Infusion of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI
CS.02 - Off the Beaten Pathologies

Ventricular Functional Response to Spinal Cord Stimulation for Advanced Heart Failure: Primary Results of the Randomized Defeat-HF Trial
CS.02 - Off the Beaten Pathologies

Efficacy of Left Ventricular Augmentation With Algisyl-LVR in the Treatment of Advanced Heart Failure Patients With Ischemic and Non-Ischemic Cardiomyopathy: Results of the AUGMENT-HF Multicenter Randomized Controlled Trial
CS.02 - Off the Beaten Pathologies

Tuesday
Late Breaking Clinical Trials
Video: Review of LBCT.03
Elliot Antman, MD; Robert Bonow, MD; Clyde Yancy, MD

Randomized Trial of Atenolol Versus Losartan in Children and Young Adults With Marfan Syndrome
LBCT.03 - Treatment of Structural Heart Disease

A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial
LBCT.03 - Treatment of Structural Heart Disease

The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
LBCT.03 - Treatment of Structural Heart Disease


The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
LBCT.03 - Treatment of Structural Heart Disease


Clinical Science: Special Reports - Morning
High-Density Lipoprotein Cholesterol Efflux Capacity is Associated With Incident First Atherosclerotic Cardiovascular Events in the Multi-Ethnic, Population-Based Dallas Heart Study
CS.04 - Trials and Cardiovascular Registries

A Cluster Randomized Controlled Trial to Evaluate The Effect of a Simplified Multifaceted Management Program in High Cardiovascular Disease Risk Patients in Rural China and India: Simcard Study
CS.04 - Trials and Cardiovascular Registries

Intention-to-Tweet: A Randomized Trial of Social Media from Circulation
CS.04 - Trials and Cardiovascular Registries

Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients with Non-MRI Conditional Pacemakers and Implantable Cardioverter Defibrillators: Final Results of The MagnaSafe Registry
CS.04 - Trials and Cardiovascular Registries


Clinical Science: Special Reports - Afternoon
On-Treatment Analysis of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)
CS.01 - Update on Randomized Trials

Lifetime Clinical and Economic Benefits of Statin-Based LDL Lowering in the 20-Year Followup of the West of Scotland Coronary Prevention Study
CS.01 - Update on Randomized Trials

Regional Analysis of Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)
CS.01 - Update on Randomized Trials

Comparison of Ischemic and Bleeding Events After Drug-Eluting Stents or Bare Metal Stents in Subjects Receiving Dual Antiplatelet Therapy: Results from the Randomized Dual Antiplatelet Therapy Study
CS.01 - Update on Randomized Trials

Wednesday
Late Breaking Clinical Trials
Video: Overview of LBCT.04
Elliott Antman, MD; Mariell Jessup, MD; Clyde Yancy, MD; Robert Bonow, MD

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial
LBCT.04 - Ischemic Heart Disease: Drugs, Devices and Systems of Care

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
LBCT.04 - Ischemic Heart Disease: Drugs, Devices and Systems of Care

A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study
LBCT.04 - Ischemic Heart Disease: Drugs, Devices and Systems of Care

Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study
LBCT.04 - Ischemic Heart Disease: Drugs, Devices and Systems of Care


Clinical Science: Special Reports
Efficacy and Safety of Combining Alirocumab With Atorvastatin or Rosuvastatin versus Statin Intensification or Adding Ezetimibe in High Cardiovascular Risk Patients: ODYSSEY OPTIONS I and II
CS.05 - Results of ODYSSEY

ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia
CS.05 - Results of ODYSSEY

Efficacy and Safety of Alirocumab in High Cardiovascular Risk Patients With Suboptimally Controlled Hypercholesterolemia on Maximally Tolerated Doses of Statins: The ODYSSEY COMBO I Study
CS.05 - Results of ODYSSEY

Long-term Safety, Tolerability and Efficacy of Alirocumab versus Placebo in 2,341 High Cardiovascular Risk Patients: ODYSSEY LONG TERM
CS.05 - Results of ODYSSEY


Other 2014 Scientific Sessions Abstracts

2014 Scientific Sessions and Resuscitation Science Symposium Abstracts
Published in Circulation

Late Breaking Basic Science Abstracts
Published in Circulation Research

 

Sessions OnDemand™

Sessions OnDemand Premium - Unlimited online & mobile access to AHA Scientific Sessions 2014. Learn more at sessionsondemand.org

Scientific Sessions 2014 Daily News

  • ss14_dailyNews_saturday.jpg
  • Sessions 2014 Daily News - Sunday
  • Sessions Daily News - Monday
  • Sessions Daily News - Tuesday
  • Daily News - Wednesday

Daily News - Wednesday

  

Who's Talking About #AHA14

 

Scientific Sessions 2014 Press Releases

See Tip Sheets, Videos and Press Releases in the Heart.org Newsroom

Read Daily posts on Blog.Heart.org